The U.S. Food & Drug Administration (FDA) recently released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market.  The Food and Drug Omnibus Reform Act of 2022 directed the FDA to work with the Department …

FDA National Strategy to Further Increase U.S. Infant Formula Market Resiliency Read more »